HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Relief of symptoms after gefitinib is associated with improvement of rest/activity rhythm in advanced lung cancer.

AuthorsIda Iurisci, Tyvin Rich, Francis Lévi, Pasquale F Innominato, Nicola Tinari, Luciana Irtelli, Michele De Tursi, Antonino Grassadonia, Stefano Iacobelli
JournalJournal of clinical oncology : official journal of the American Society of Clinical Oncology (J Clin Oncol) Vol. 25 Issue 16 Pg. e17-9 (Jun 01 2007) ISSN: 1527-7755 [Electronic] United States
PMID17538154 (Publication Type: Letter, Comment)
Chemical References
  • Antineoplastic Agents
  • Quinazolines
  • Gefitinib
Topics
  • Antineoplastic Agents (therapeutic use)
  • Carcinoma, Non-Small-Cell Lung (drug therapy, physiopathology, psychology)
  • Circadian Rhythm
  • Gefitinib
  • Humans
  • Lung Neoplasms (drug therapy, physiopathology, psychology)
  • Quality of Life
  • Quinazolines (therapeutic use)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: